9 results
Main causes of diffuse parenchymal lung diseases.

#differential #algorithm #diagnosis #causes #DPLD #ILD #parenchymal #lung #diseases #pulmonary
Main causes of diffuse ... #differential #algorithm ... #diagnosis #causes ... #DPLD #ILD #parenchymal
Algorithmic Approach to Acute Interstitial Nephritis
When to suspect AIN? (not sensitive)
 • AKI, AKD, rapidly progressive
Algorithmic Approach ... microscopic hematuria, mild ... Received drug associated ... #Algorithm #nephrology ... #diagnosis
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Algorithm • 40- ... correction of lab abn ... /other causes • ... #Algorithm #diagnosis ... #management
Algorithm for Diagnosis of Diffuse Cystic Lung Disease (DCLD)
Round, smooth cysts with normal lung parenchyma in
Algorithm for Diagnosis ... May have associated ... presentations - ILD ... DCLD #pulmonary #Algorithm ... #Diagnosis #differential
Efforts to standardize the approach to trauma have led to an algorithmic, thoughtless approach to trauma
algorithmic, thoughtless ... ill patients. ... as the critical diagnostic ... witnessed many cases ... #Management #Trauma
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
is rare but is associated ... • Patchy or diffuse ... Exclude other causes ... Exclusion of other ILDs ... #management #Toxicology
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
treat the primary cause ... vessels, or acutely ill ... may not be the case ... #diagnosis #management ... clinica l#foamed #algorithm
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
treat the primary cause ... vessels, or acutely ill ... may not be the case ... #diagnosis #algorithm ... echocardiogram #management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... ET-associated mutation ... hemoproliferative disorder associated ... • Treatment algorithms ... #management #hematology